Skip to content

Analgesic effect of esketamine in dressing change for severe burns in adults: a prospective randomized controlled study

Analgesic effect of esketamine in dressing change for severe burns in adults: a prospective randomized controlled study

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2200063137
Enrollment
Unknown
Registered
2022-08-31
Start date
2022-09-01
Completion date
Unknown
Last updated
2023-04-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Burn

Interventions

Experimental group:Use esketamine before dressing for burns
Control group:Do not use esketamine before dressing for burns

Sponsors

Shenzhen Second People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 60 Years

Inclusion criteria

Inclusion criteria: 1. American Society of Anesthesiologists ASA grade II to ?; 2. Patients with severe or above burns; 3. Aged range from 18 to 60 years; 4. Patients who signed informed consent.

Exclusion criteria

Exclusion criteria: 1. Liver and kidney insufficiency; 2. Allergic to the drug to be used; 3. History of antidepressant or antipsychotic drug use; 4. Second degree and above atrioventricular block; 5. Uncooperative patients.

Design outcomes

Primary

MeasureTime frame
The dosage of the remedy fentanyl;

Secondary

MeasureTime frame
Pain score after awakening;Incidence of complications associated with supervised sedation;Incidence of nausea and vomiting;The recovery time;Incidence of early depression;Operation satisfaction of physicians in the department of burn;Patients' satisfaction with dressing change;Percentage of patients requiring fentanyl as a remedy;Incidence of serious complications associated with burns;

Countries

China

Contacts

Public ContactLiu Zhiheng

Shenzhen Second People's Hospital

zhiheng_liu_tongji@163.com+86 15818505570

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026